SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-007730
Filing Date
2021-03-31
Accepted
2021-03-31 06:05:50
Documents
15
Period of Report
2021-03-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K blgo20210330_8k.htm 8-K 27408
2 EXHIBIT 99.1 ex_238396.htm EX-99.1 11558
3 EXHIBIT 99.2 ex_238397.htm EX-99.2 23037
4 EXHIBIT 99.3 ex_238398.htm EX-99.3 7464
5 slide01.jpg GRAPHIC 99355
6 slide02.jpg GRAPHIC 72561
7 slide03.jpg GRAPHIC 97105
8 slide04.jpg GRAPHIC 86946
9 slide05.jpg GRAPHIC 111135
10 slide06.jpg GRAPHIC 59859
11 slide07.jpg GRAPHIC 121663
12 slide08.jpg GRAPHIC 118286
13 slide09.jpg GRAPHIC 128767
14 slide10.jpg GRAPHIC 67278
15 slide11.jpg GRAPHIC 86588
  Complete submission text file 0001437749-21-007730.txt   1515642
Mailing Address 14921 CHESTNUT ST. WESTMINSTER CA 92683
Business Address 14921 CHESTNUT ST. WESTMINSTER CA 92683 888 400-2863
BIOLARGO, INC. (Filer) CIK: 0000880242 (see all company filings)

IRS No.: 650159115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19709 | Film No.: 21789649
SIC: 2800 Chemicals & Allied Products